Spyre Therapeutics, Inc. (SYRE)
106.65
+0.16
(+0.15%)
USD |
NASDAQ |
Aug 24, 16:00
107.01
+0.36
(+0.34%)
Pre-Market: 08:09
Spyre Therapeutics Shareholders Equity (Quarterly) : 1.101B for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.101B |
| March 31, 2026 | 670.81M |
| December 31, 2025 | 715.24M |
| September 30, 2025 | 455.10M |
| June 30, 2025 | 455.77M |
| March 31, 2025 | 482.61M |
| December 31, 2024 | 517.80M |
| September 30, 2024 | 327.39M |
| June 30, 2024 | 374.38M |
| March 31, 2024 | 152.27M |
| December 31, 2023 | 184.02M |
| September 30, 2023 | -245.40M |
| June 30, 2023 | -207.37M |
| March 31, 2023 | 33.65M |
| December 31, 2022 | 50.30M |
| September 30, 2022 | 67.56M |
| June 30, 2022 | 84.16M |
| March 31, 2022 | 61.66M |
| December 31, 2021 | 83.94M |
| September 30, 2021 | 102.08M |
| June 30, 2021 | 119.02M |
| March 31, 2021 | 123.76M |
| December 31, 2020 | 139.83M |
| September 30, 2020 | 136.27M |
| Date | Value |
|---|---|
| June 30, 2020 | 152.26M |
| March 31, 2020 | 42.80M |
| December 31, 2019 | 60.08M |
| September 30, 2019 | 79.80M |
| June 30, 2019 | 99.62M |
| March 31, 2019 | 116.29M |
| December 31, 2018 | 67.43M |
| September 30, 2018 | 63.68M |
| June 30, 2018 | 73.45M |
| March 31, 2018 | 43.92M |
| December 31, 2017 | 50.34M |
| September 30, 2017 | 55.51M |
| June 30, 2017 | 62.60M |
| March 31, 2017 | 57.18M |
| December 31, 2016 | 62.97M |
| September 30, 2016 | 68.20M |
| June 30, 2016 | 73.92M |
| March 31, 2016 | 31.70M |
| December 31, 2015 | 36.10M |
| September 30, 2015 | 39.65M |
| June 30, 2015 | 42.90M |
| March 31, 2015 | 43.12M |
| December 31, 2014 | 1.872M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -5.935B |
| vTv Therapeutics, Inc. | 78.63M |
| BridgeBio Pharma, Inc. | -2.515B |
| Praxis Precision Medicines, Inc. | 1.341B |
| ACADIA Pharmaceuticals, Inc. | 1.307B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.173B |
| Total Liabilities (Quarterly) | 71.86M |
| Current Ratio | 18.53 |